Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
san diego blog main
3
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
bristol-myers squibb
clinical trials
spark therapeutics
vertex pharmaceuticals
2019
abeona therapeutics
accent therapeutics
achilles therapeutics
activism
acute hepatic porphyria
akouos
alder biopharmaceuticals
What
bio
drug
3
×
roundup
gene
patients
therapy
advanced
advantages
alnylam’s
approval
aren’t
bar
bff
brings
conference
deals
developers
devoted
disease
drugs
easl
expect
fda
form
gamble
help
imminent
kicked
liver
long
major
market
medco’s
medicare
mover
moves
new
news
noteworthy
payers
Language
unset
Current search:
drug
×
" san diego blog main "
×
" raleigh-durham blog main "
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More